REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences:
TD Cowen's 45th Annual Health Care ConferenceFireside Chat: Wednesday, March 5 at 1:10pm ETLocation: Boston, MA
Leerink Partners Global Healthcare ConferenceFireside Chat: Tuesday, March 11 at 9:20am ETLocation: Miami, FL
Barclays 27th Annual Global Healthcare ConferenceFireside Chat: Wednesday, March 12 at 3:30pm ETLocation: Miami, FL
UBS Virtual CNS DayFireside Chat: Monday, March 17 at 10:00am ETLocation: Virtual
RBC Inaugural Virtual Ophthalmology ConferenceFireside Chat: April 3 at 8:15am ETLocation: Virtual
Live webcasts of select fireside chats can be accessed in the Investors section of REGENXBIO's website at www.regenxbio.com. An archived replay of the webcast will be available for approximately 30 days following the presentation.
ABOUT REGENXBIO Inc.REGENXBIOis a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009,REGENXBIOhas pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines.REGENXBIOis advancing a pipeline of AAV Therapeutics for rare and retinal diseases, including RGX-202 for the treatment of Duchenne, ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, and RGX-121 for the treatment of MPS II. Thousands of patients have been treated withREGENXBIO'sAAV Therapeutic platform, including Novartis' Zolgensma®for children with spinal muscular atrophy. Designed to be one-time treatments, AAV Therapeutics have the potential to change the way healthcare is delivered for millions of people. For more information, please visit WWW.REGENXBIO.COM.
Contacts:
DanaCormackCorporate Communicationsdcormack@regenxbio.com
Investors:George E. MacDougallInvestor RelationsIR@regenxbio.com
https://mma.prnewswire.com/media/684531/RGNX_Logo.jpg
https://c212.net/c/img/favicon.png?sn=PH27346&sd=2025-02-25
View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-302385213.html
SOURCE REGENXBIO Inc.
https://rt.newswire.ca/rt.gif?NewsItemId=PH27346&Transmission_Id=202502251605PR_NEWS_USPR_____PH27346&DateId=20250225